7,133 Shares in Cardinal Health, Inc. (NYSE:CAH) Purchased by Allstate Corp

Allstate Corp bought a new stake in Cardinal Health, Inc. (NYSE:CAH) during the fourth quarter, Holdings Channel.com reports. The fund bought 7,133 shares of the company’s stock, valued at approximately $844,000.

Several other institutional investors also recently added to or reduced their stakes in the business. Cyrus J. Lawrence LLC bought a new position in Cardinal Health during the fourth quarter worth $26,000. Promus Capital LLC acquired a new stake in Cardinal Health in the 4th quarter worth $30,000. Lee Danner & Bass Inc. acquired a new position in shares of Cardinal Health during the fourth quarter valued at about $35,000. Kentucky Trust Co bought a new stake in shares of Cardinal Health in the fourth quarter valued at about $41,000. Finally, HHM Wealth Advisors LLC grew its position in Cardinal Health by 57.6% during the fourth quarter. HHM Wealth Advisors LLC now owns 394 shares of the company’s stock worth $47,000 after buying an additional 144 shares in the last quarter. 87.17% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several equities analysts have commented on the company. Citigroup upped their price target on Cardinal Health from $120.00 to $129.00 and gave the company a “neutral” rating in a report on Friday, January 10th. JPMorgan Chase & Co. upped their target price on Cardinal Health from $142.00 to $145.00 and gave the company a “neutral” rating in a research note on Tuesday, February 4th. TD Cowen upgraded shares of Cardinal Health from a “hold” rating to a “buy” rating and lifted their price target for the stock from $130.00 to $144.00 in a research note on Wednesday, January 8th. Bank of America raised shares of Cardinal Health from a “neutral” rating to a “buy” rating and boosted their price target for the company from $132.00 to $145.00 in a report on Monday, January 6th. Finally, Jefferies Financial Group upgraded shares of Cardinal Health from a “hold” rating to a “buy” rating and lifted their target price for the company from $140.00 to $150.00 in a research report on Wednesday, February 5th. Four equities research analysts have rated the stock with a hold rating and eleven have given a buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $140.14.

Cardinal Health Price Performance

Shares of CAH opened at $137.83 on Tuesday. The company has a market capitalization of $33.29 billion, a P/E ratio of 25.71, a PEG ratio of 1.49 and a beta of 0.66. Cardinal Health, Inc. has a one year low of $93.17 and a one year high of $138.62. The business’s 50 day simple moving average is $128.60 and its 200-day simple moving average is $121.03.

Cardinal Health (NYSE:CAH) last announced its earnings results on Thursday, January 30th. The company reported $1.93 EPS for the quarter, topping the consensus estimate of $1.74 by $0.19. Cardinal Health had a negative return on equity of 59.57% and a net margin of 0.59%. On average, sell-side analysts anticipate that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.

Cardinal Health Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 15th. Shareholders of record on Tuesday, April 1st will be given a $0.5056 dividend. This represents a $2.02 annualized dividend and a yield of 1.47%. The ex-dividend date is Tuesday, April 1st. Cardinal Health’s payout ratio is presently 37.69%.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.